Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.70 |
---|---|
High | 1.70 |
Low | 1.70 |
Bid | 1.69 |
Offer | 1.75 |
Previous close | 1.74 |
Average volume | 10.67k |
---|---|
Shares outstanding | 395.08m |
Free float | 169.50m |
P/E (TTM) | -- |
Market cap | 673.61m NOK |
EPS (TTM) | -0.3023 NOK |
Data delayed at least 15 minutes, as of Sep 20 2024 08:59 BST.
More ▼
Announcements
- Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT
- Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY
- Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.
- Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
- Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT
- Hofseth Biocare ASA: Annual General Meeting completed
- Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024
- Hofseth Biocare ASA: HBC ANNUAL REPORT 2023
- Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING
- Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION
More ▼